Hualin Zhang1, Yupeng Li1,2,3

  • 1Department of Chemistry and Biochemistry, The University of Texas at El Paso, El Paso, Texas 79968, United States.

PubMed
まとめ

グリオブラストーマの治療は,特にMGMT非メチル化症例において,テモゾロミド (TMZ) 耐性で困難に直面する. 研究は,新しいTMZ誘導体と組み合わせを研究し,多形性膠芽細胞腫の生存率を向上させることに焦点を当てています.

関連する概念動画

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K